Please assess the completion status of the following clinical trial:

Trial Title: Study of DE-089 Ophthalmic Solution in Patients With Dry Eye

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Those who show:~  * Keratoconjunctival disorder confirmed with vital dye staining~ * Abnormal Schirmer score results~Exclusion Criteria:~* Eye disease that needs therapy other than that for dry eye~* Those who need to wear contact lenses during the clinical study

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Study Arms:
- DE-089 (Type: EXPERIMENTAL): DE-089 ophthalmic solution
- HA (Type: ACTIVE_COMPARATOR): 0.1% sodium hyaluronate ophthalmic solution

Based on this trial design, predict the completion outcome and termination type (if applicable).